Friday, 25 September 2026European Markets

PASSAT Stock Jump On Wednesday, Outperforms Market

Loading stream...

(vianews) - the market ended the session with passat (psat.pa) jumping 9.86% to €4.68 on wednesday, after two consecutive sessions in a row of gains. cac 40 slid 0.49% to €7,361.20, following the last session's downward trend on what was a somewhat down trend trading session today.

passat's last close was €4.26, 22.83% under its 52-week high of €5.52.

about passat

passat société anonyme engages in the image-assisted sale of consumer products in france. the company sell household, kitchen, diy, garden, beauty, and leisure and fitness products. passat société anonyme was founded in 1987 and is headquartered in fourqueux, france.

earnings per share

as for profitability, passat has a trailing twelve months eps of €0.06.

pe ratio

passat has a trailing twelve months price to earnings ratio of 78. meaning, the purchaser of the share is investing €78 for every euro of annual earnings.

more news about passat (psat.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI Agents Scale Up Through Partnerships and Funding, But Data Readiness Lags Ambition
A wave of vertical AI-agent startups (Swarm, Veridox, Avallon AI, DA2, F2, Earthian, Meanwhile, Covecta, Penguin AI, Maisa AI) is being funded and profiled just as major infrastructure players — Microsoft/Mistral, Siemens/NVIDIA, and Manulife/Microsoft — cement enterprise AI governance and compute partnerships. Yet a Google Cloud report shows AI agents still lack access to the majority of company data (only 45% on average), and insider selling at incumbent C3.ai signals investor caution even as adoption intent (100% planned agentic AI use within two years) races ahead of actual data infrastructure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,984
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,984 facts checked against source5,306 source documents archived
Query this data → isubstrate.com